Serum lipid peroxides in rats treated chronically with adriamycin

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Adriamycin (doxorubicin) is a widely used anticancer agent.
• Chronic adriamycin administration can lead to cardiotoxicity.
• The precise mechanisms underlying adriamycin toxicity are not fully elucidated.

Purpose of the Study:

• To investigate the effects of chronic adriamycin treatment on lipid metabolism in rats.
• To determine if adriamycin induces lipid peroxidation in vivo.
• To explore the association between lipid peroxidation and adriamycin-induced cardiomyopathy.

Main Methods:

• Rats were treated chronically with adriamycin.
• Serum lipid peroxides were measured using thiobarbituric acid reactivity and iodometric titration.
• Lipid fractionation was performed to identify the lipid classes associated with peroxides.
• Lipoprotein classes were analyzed for peroxide distribution.

Main Results:

• Adriamycin-treated rats showed elevated serum lipid peroxides and hyperlipidemia.
• Both lipid endoperoxides and hydroperoxides were detected.
• Lipid peroxides were primarily found in neutral lipids (triglycerides, cholesterol esters, cholesterol), not phospholipids.
• Peroxides were distributed across major serum lipoprotein classes.
• The dose-dependent increase in lipid peroxides correlated with the dose required for cardiomyopathy.

Conclusions:

• Chronic adriamycin treatment induces significant lipid peroxidation in rat serum.
• Lipid peroxides are predominantly associated with neutral lipids and distributed among lipoprotein fractions.
• In vivo formation of lipid peroxides is a likely consequence of chronic adriamycin administration.
• Lipid peroxidation may play a role in the development of adriamycin-induced cardiomyopathy.